Clinical Trial Update: Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating an adsorbed, acellular pertussis vaccine component combined with Hib and ACWY meningococcal components; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Meningitis
• Meningococcal Disease
• Pertussis
• Tetanus

Drugs mentioned

• Adsorbed Acellular Pertussis (Tricomponent) DTaP-Hib-ACWY135 Group Meningococcal Conjugate Vaccine

Snippet

Sponsor: CanSino Biologics Inc. | Conditions: Diphtheria, Tetanus and Acellular Pertussis, Epidemic Meningitis | Phase 1 | Status: RECRUITING